Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
Now available on-demand! Cracking the code: learnings from oligonucleotide method development WATCH NOW

Land O’Lakes: Biomarkers and Dealing with Endogeneous Analytics (Binodh DeSilva)

10 Jul 2014
Clinical LBA Regulated bioanalysis

In collaboration with the event organizers, University of Wisconsin, Bioanalysis Zone is pleased to feature a presentation by Binodh DeSilva on ‘Biomarkers and Dealing with Endogeneous Analytics’ from the 15th Annual Land O’Lakes Bioanalytical Conference, July 21-24 2014.

More presentations from the 15th  Land O’Lakes Bioanalytical Conference:

Biosimilars from a Clinical and Regulatory Perspective (Hazel Gorham)

Responses to and Potential Impact of the New FDA Guidance on Bioanalysis with Large Molecules (Marian Kelley)

Bioanalytical Assays for Biosimilars (Xun Wang)

Related tags

protein
Previous article Next article

Related articles

13 APR 2015 CLINICAL
Skin biopsies could provide new insights into Parkinson’s and Alzheimer’s disease
10 APR 2014 DRUG DEVELOPMENT
Bioanalysis for plasma protein binding studies in drug discovery and drug development: views and recommendations of the European Bioanalysis Forum
31 MAR 2009 COLLABORATIONS AND MERGERS
Conference Report: Europen Bioanalysis Forum
21 OCT 2015 DIAGNOSTICS
Novel electrochemical sensor may be used to develop point-of-care diagnostic device
1 APR 2011 CLINICAL
Making the cut: untangling clinical protein biomarker discovery and validation
31 MAR 2016 MS (LC–MS/MS, HRMS, IMS)
Internal Standard Considerations for Protein Therapeutic Bioanalytical LC-MS/MS Assays
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone